Advisory Committees

February 25-26, 2014: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Agenda- February 25, 2014

Food and Drug Administration
Cellular, Tissue and Gene Therapies Advisory Committee
Meeting #59
February 25-26, 2014

Agenda: Tuesday, February 25, 2014
8:00 a.m.Opening Remarks
Evan Snyder, M.D., Ph.D., Chair

Conflict of Interest Statement
Gail Dapolito, Designated Federal Officer

Introduction of Members
Topic I: Oocyte Modification in Assisted Reproduction for the Prevention of Transmission of Mitochondrial disease or treatment of Infertility
8:15FDA Introduction
Celia Witten, Ph.D., M.D.
Office of Cellular, Tissue and Gene Therapies
8:20FDA Presentation
Deborah Hursh, Ph.D.
Office of Cellular, Tissue and Gene Therapies
Research and Science Presentations
8:40Gerald Shadel, Ph.D.
Yale University
9:05Q&A
9:20Salvatore DiMauro, M.D.
Columbia University
9:45Q&A
10:00Break
10:15Marc-André Sirard, D.M.V., Ph.D.
Université Laval
10:40Q&A
10:55Keith Latham, Ph.D.
Michigan State University
11:20Q&A
11:35Shoukhrat Mitalipov, Ph.D.
Oregon Health and Science University
11:55Q&A
12:10 p.m.Dieter Egli, Ph.D.
Columbia University
New York Stem Cell Foundation Research Institute
12:30Q&A
12:45Lunch
1:45Mary Herbert, Ph.D.
Newcastle University
2:05Q&A
2:20Open Public Hearing
3:20Break
3:30Committee Discussion of Questions
5:30 p.m.Adjourn

Page Last Updated: 08/20/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.